Advanced search
1 file | 1.76 MB Add to list

Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie?

(2018) BRITISH JOURNAL OF CANCER. 119(4). p.389-407
Author
Organization
Abstract
As we mark 150 years since the birth of Marie Curie, we reflect on the global advances made in radiation oncology and the current status of radiation therapy (RT) research. Large-scale international RT clinical trials have been fundamental in driving evidence-based change and have served to improve cancer management and to reduce side effects. Radiation therapy trials have also improved practice by increasing quality assurance and consistency in treatment protocols across multiple centres. This review summarises some of the key RT practice-changing clinical trials over the last two decades, in four common cancer sites for which RT is a crucial component of curative treatment: breast, lung, urological and lower gastro-intestinal cancer. We highlight the global inequality in access to RT, and the work of international organisations, such as the International Atomic Energy Agency (IAEA), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the United Kingdom National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad), that aim to improve access to RT and facilitate radiation research. We discuss some emerging RT technologies including proton beam therapy and magnetic resonance linear accelerators and predict likely future directions in clinical RT research.
Keywords
CELL LUNG-CANCER, EARLY BREAST-CANCER, RANDOMIZED CONTROLLED-TRIAL, QUALITY-OF-LIFE, TOTAL MESORECTAL EXCISION, CONVENTIONALLY FRACTIONATED RADIOTHERAPY, CLINICAL-PRACTICE GUIDELINES, LOCALIZED PROSTATE-CANCER, PHASE-III TRIAL, NO BOOST TRIAL

Downloads

  • Thompson practice changing RT trials BJC 2018.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 1.76 MB

Citation

Please use this url to cite or link to this publication:

MLA
Thompson, Mareike K et al. “Practice-changing Radiation Therapy Trials for the Treatment of Cancer : Where Are We 150 Years After the Birth of Marie Curie?” BRITISH JOURNAL OF CANCER 119.4 (2018): 389–407. Print.
APA
Thompson, M. K., Poortmans, P., Chalmers, A. J., Faivre-Finn, C., Hall, E., Huddart, R. A., Lievens, Y., et al. (2018). Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie? BRITISH JOURNAL OF CANCER, 119(4), 389–407.
Chicago author-date
Thompson, Mareike K, Philip Poortmans, Anthony J Chalmers, Corinne Faivre-Finn, Emma Hall, Robert A Huddart, Yolande Lievens, David Sebag-Montefiore, and Charlotte E Coles. 2018. “Practice-changing Radiation Therapy Trials for the Treatment of Cancer : Where Are We 150 Years After the Birth of Marie Curie?” British Journal of Cancer 119 (4): 389–407.
Chicago author-date (all authors)
Thompson, Mareike K, Philip Poortmans, Anthony J Chalmers, Corinne Faivre-Finn, Emma Hall, Robert A Huddart, Yolande Lievens, David Sebag-Montefiore, and Charlotte E Coles. 2018. “Practice-changing Radiation Therapy Trials for the Treatment of Cancer : Where Are We 150 Years After the Birth of Marie Curie?” British Journal of Cancer 119 (4): 389–407.
Vancouver
1.
Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, et al. Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie? BRITISH JOURNAL OF CANCER. 2018;119(4):389–407.
IEEE
[1]
M. K. Thompson et al., “Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie?,” BRITISH JOURNAL OF CANCER, vol. 119, no. 4, pp. 389–407, 2018.
@article{8591713,
  abstract     = {As we mark 150 years since the birth of Marie Curie, we reflect on the global advances made in radiation oncology and the current status of radiation therapy (RT) research. Large-scale international RT clinical trials have been fundamental in driving evidence-based change and have served to improve cancer management and to reduce side effects. Radiation therapy trials have also improved practice by increasing quality assurance and consistency in treatment protocols across multiple centres. This review summarises some of the key RT practice-changing clinical trials over the last two decades, in four common cancer sites for which RT is a crucial component of curative treatment: breast, lung, urological and lower gastro-intestinal cancer. We highlight the global inequality in access to RT, and the work of international organisations, such as the International Atomic Energy Agency (IAEA), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the United Kingdom National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad), that aim to improve access to RT and facilitate radiation research. We discuss some emerging RT technologies including proton beam therapy and magnetic resonance linear accelerators and predict likely future directions in clinical RT research.},
  author       = {Thompson, Mareike K and Poortmans, Philip and Chalmers, Anthony J and Faivre-Finn, Corinne and Hall, Emma and Huddart, Robert A and Lievens, Yolande and Sebag-Montefiore, David and Coles, Charlotte E},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  keywords     = {CELL LUNG-CANCER,EARLY BREAST-CANCER,RANDOMIZED CONTROLLED-TRIAL,QUALITY-OF-LIFE,TOTAL MESORECTAL EXCISION,CONVENTIONALLY FRACTIONATED RADIOTHERAPY,CLINICAL-PRACTICE GUIDELINES,LOCALIZED PROSTATE-CANCER,PHASE-III TRIAL,NO BOOST TRIAL},
  language     = {eng},
  number       = {4},
  pages        = {389--407},
  title        = {Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie?},
  url          = {http://dx.doi.org/10.1038/s41416-018-0201-z},
  volume       = {119},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: